Skip to main content
Journal cover image

339. Sustained, High-Level Expression of Human Acid Alpha-Glucosidase and Correction of Glycogen Storage Disease Type II (GSD II) with an Adeno-Associated Virus 8 (AAV2/8) Vector Containing a Liver-Specific Promoter

Publication ,  Conference
Franco, LM; Sun, B; Bird, A; Zhang, H; Amalfitano, A; Chen, Y-T; Koeberl, DD
Published in: Molecular Therapy
May 2004

Duke Scholars

Published In

Molecular Therapy

DOI

ISSN

1525-0016

Publication Date

May 2004

Volume

9

Start / End Page

S129 / S129

Publisher

Elsevier BV

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Franco, L. M., Sun, B., Bird, A., Zhang, H., Amalfitano, A., Chen, Y.-T., & Koeberl, D. D. (2004). 339. Sustained, High-Level Expression of Human Acid Alpha-Glucosidase and Correction of Glycogen Storage Disease Type II (GSD II) with an Adeno-Associated Virus 8 (AAV2/8) Vector Containing a Liver-Specific Promoter. In Molecular Therapy (Vol. 9, pp. S129–S129). Elsevier BV. https://doi.org/10.1038/mt.2004.1400
Franco, Luis M., Baodong Sun, Andrew Bird, Haoyue Zhang, Andrea Amalfitano, Y. -. T. Chen, and Dwight D. Koeberl. “339. Sustained, High-Level Expression of Human Acid Alpha-Glucosidase and Correction of Glycogen Storage Disease Type II (GSD II) with an Adeno-Associated Virus 8 (AAV2/8) Vector Containing a Liver-Specific Promoter.” In Molecular Therapy, 9:S129–S129. Elsevier BV, 2004. https://doi.org/10.1038/mt.2004.1400.
Journal cover image

Published In

Molecular Therapy

DOI

ISSN

1525-0016

Publication Date

May 2004

Volume

9

Start / End Page

S129 / S129

Publisher

Elsevier BV

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences